Screener
Kiniksa Pharmaceuticals International, plc KNSA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on the most recent quarter.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's current ratio?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported current ratio of 3.9× in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's current ratio changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's current ratio increased by 9.5% year-over-year, from 3.6× to 3.9×.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's current ratio?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's current ratio has grown at a -18.4% compound annual growth rate (CAGR), from 10.5× to 3.8×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Kiniksa Pharmaceuticals International, plc's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude